Aldonza, M. B. D., Reyes, R. D. D., Kim, Y. S., Ku, J., Barsallo, A. M., Hong, J., . . . Kim, Y. (2021). Chemotherapy confers a conserved secondary tolerance to EGFR inhibition via AXL-mediated signaling bypass. Nature Portfolio.
Chicago Style (17th ed.) CitationAldonza, Mark Borris D., et al. Chemotherapy Confers a Conserved Secondary Tolerance to EGFR Inhibition via AXL-mediated Signaling Bypass. Nature Portfolio, 2021.
MLA (8th ed.) CitationAldonza, Mark Borris D., et al. Chemotherapy Confers a Conserved Secondary Tolerance to EGFR Inhibition via AXL-mediated Signaling Bypass. Nature Portfolio, 2021.
Warning: These citations may not always be 100% accurate.